Open AccessMinimal inhibitory concentrations of first-line drugs of multidrug -resistant tuberculosis isolates
Author(s) -
Nicolas Schönfeld,
Thorsten Bergmann,
Silvan Vesenbeckh,
H. Mauch,
Gudrun Bettermann,
Torsten Bauer,
Holger Rüssmann
Publication year - 2012
Publication title -
lung india
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 25
eISSN - 0974-598X
pISSN - 0970-2113
DOI - 10.4103/0970-2113.102794
Subject(s) - ethambutol , isoniazid , rifampicin , streptomycin , medicine , tuberculosis , drug resistance , mycobacterium tuberculosis , minimum inhibitory concentration , microbiology and biotechnology , multiple drug resistance , drug , pharmacology , antibiotics , biology , pathology
The treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) is consistently difficult. Besides resistances, drug availability can be problematic and costs for therapy are high.